Advertisement

Topics

Dr. Reddy's Laboratories Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

22:06 EDT 28 Sep 2018 | BioPortfolio Reports

Dr. Reddy's Laboratories Limited Strategy, SWOT and Corporate Finance Report


Summary


Dr. Reddy's Laboratories Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Dr. Reddy's Laboratories DRL or 'the company' is an integrated pharmaceutical company that offers generics, over the counter, active pharmaceutical ingredients APIs, and proprietary products. The generics products are ready for consumption by the customer product and specified for the areas of gastrointestinal, cardiovascular, pain management, oncology, antiinfectives, pediatrics and central nervous system. It also offers pharmaceutical services and active ingredients product that consists of active pharmaceutical products or bulk drugs. DRL is engaged in the discovery of new chemical entities for the areas of metabolic disorders, pain and inflammation. The company operates in India, North America, Europe, Russia and other countries of the former Soviet Union. DRL is headquartered in Hyderabad,Telengana, India.


Scope


Detailed information on Dr. Reddy's Laboratories Limited required for business and competitor intelligence needs

A study of the major internal and external factors affecting Dr. Reddy's Laboratories Limited in the form of a SWOT analysis

An indepth view of the business model of Dr. Reddy's Laboratories Limited including a breakdown and examination of key business segments

Intelligence on Dr. Reddy's Laboratories Limited's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Dr. Reddy's Laboratories Limited, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Dr. Reddy's Laboratories Limited and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Dr. Reddy's Laboratories Limited as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Dr. Reddy's Laboratories Limited's business structure, strategy and prospects.

Original Article: Dr. Reddy's Laboratories Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy's Laboratories Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...